Omnicell Announces Financial Results for First Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Omnicell (OMCL) Tops Q1 EPS by 17c, Revenues Beat; Offers FY21 EPS/Revenues Mid-Point Outlook Above Consensus, Offers 2Q Revs. View Above Est.
April 29, 2021 4:36 PM EDTOmnicell (NASDAQ: OMCL) reported Q1 EPS of $0.83, $0.17 better than the analyst estimate of $0.66. Revenue for the quarter came in at $251.84 million versus the consensus estimate of $246.7 million.
We delivered an exceptionally strong first quarter, exceeding our first quarter guidance and achieving record revenue for the quarter, said Randall Lipps, Chairman, President, Chief Executive Officer, and founder of Omnicell. We continue to make tremendous progress advancing the vision of the autonomous pharmacy, and we continue to see robust and growing demand for our... More
